> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Warns Mahita on Unapproved Covid Products
- URL: https://www.fdaweb.com/fda-warns-mahita-on-unapproved-covid-products/
- Published: 2021-08-24T12:00:00.000Z
- Updated: 2026-09-14T17:11:39.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149995

FDA has sent a [Warning Letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mahita-llc-dba-pushmycart-616541-08192021?ref=fdaweb.com) to Mahita, LLC (Suwanee, GA) after determining that the firm was marketing unapproved and misbranded products related to Covid-19\. The letter says its products (e.g., Pantanjali Coronil Kit) are marketed on Facebook and Amazon as a treatment for and prevention against Covid-19\. The agency requested that Mahita take immediate action to cease the sale of any unapproved and unauthorized products.